Arena Pharmaceuticals Inc. announced the appointment of Kevin Lind, as President and Chief Executive Officer of subsidiary, Arena Neuroscience Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.87 USD | +5.42% | +0.37% | +212.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+212.94% | 734M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- LBPH Stock
- News Longboard Pharmaceuticals, Inc.
- Arena Neuroscience, Inc. Announces Appointment of Kevin Lind as President and Chief Executive Officer